Q: Pfe had tumbled from 52 week H of $54.93 to recent 52 week low of $36.17.Very positive reaction to the tune of + 4.87%(at $38.56) to today's favourable peer reviewed study of oral drug for weight loss. In light of the above,is it timely to buy some? Txs for U usual great services & views.Happy Victoria Day
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Any thoughts on WELL's new acquisition in Calgary?
Q: What are your current thoughts on this company (TNDM) and do you think it has bottomed? Thanks as usual.
Q: Which would be your choice to initiate a new position. $ISRG or $SYK?
Q: I have been slowly accumulating ISRG. It has just gone above its 52 week high. Considering another small purchase based on hopefully continued momentum. Is it still a good long term plan or time to pause and wait for a pull back and better valuation? Thanks
Mike
Mike
Q: At first glance, today's earnings look pretty good. But similar to WELL, we are again seeing a significant downward move on the SP. The difference is that the trading volume is pretty modest so it could just be a few retail investors that are "selling on the news." At any rate, would appreciate your views.
Q: Hi- would be interested in your analysis of Well vs. Qipt- if you had to choose one today for small cap healthcare
Q: What are your thoughts on MDT these days? Worth investing at current levels? thanks
Q: Hello,
Can you comment on the recent earnings and the outlook going forward?
Can you comment on the recent earnings and the outlook going forward?
Q: What are your thoughts on NNOX? Lots of chatter about JNJ increasing stake and the stock is up significantly. Is this investable?
Q: I own both of these stocks and was considering consolidation, but only if there's some sense in doing so. The market liked the EXAS results. Are they different enough that owning both is fine? If only one, which one is better long term?
Q: Please your comments on the recent financing through shares at 20% below market price. Future prospects? Good value at current price?
Q: Just a comment when a guest asks why the stock is going down in the day, and a lot of the time the answer is selling because the stock is up 60% this year, but this stock was bought was probably bought many 5i clients when it was recommended as a buy in the 8 dollar level two years, sometimes I wish 5i would say get out of this stock, sell, it is so over priced, you sare not investing, just gambling. I just feel that a lot of investors need more help when to be lest GRČEDY.
Q: Comment on there earnings?
Q: Hi Team,
Well is still tanking today. (-8%) on no news. Is this latest weakness all profit taking? I see no negative news? Has a big shareholder been dumping the stock? This action is somewhat confusing after such strength in the name previously.
Well is still tanking today. (-8%) on no news. Is this latest weakness all profit taking? I see no negative news? Has a big shareholder been dumping the stock? This action is somewhat confusing after such strength in the name previously.
Q: i have the three health care stocks. i want to reduceto only .two
Which i the one i eed to let go
Which i the one i eed to let go
Q: Hi Peter,
I recently discovered ABC company. I hadn't heard of it before. Upon further investigation, I was impressed by its consistent outperformance of estimates and excellent track record. It reminds me of CSU. What is your opinion on this company? Could you provide some pros and cons for long-term investment? Also, are there any other better options in the medical industry?
Best,
Matt
I recently discovered ABC company. I hadn't heard of it before. Upon further investigation, I was impressed by its consistent outperformance of estimates and excellent track record. It reminds me of CSU. What is your opinion on this company? Could you provide some pros and cons for long-term investment? Also, are there any other better options in the medical industry?
Best,
Matt
Q: Hi,
HEPION Parma (HEPA-US: not in your database) had a 1/20 reverse stock split this week. Taking this into account, the stock is still nearly down 50% in 2 days. Liver/ NASH disease is a good research target. Any news I did not see?
Have a great week-end. Thanks
HEPION Parma (HEPA-US: not in your database) had a 1/20 reverse stock split this week. Taking this into account, the stock is still nearly down 50% in 2 days. Liver/ NASH disease is a good research target. Any news I did not see?
Have a great week-end. Thanks
Q: Do not own either, but would like to own both, any problem buying them now?
Thanks Again
Thanks Again
Q: This is more of a statement then a question. I am so disappointed in the stock market. WELL is down so far today off those results. It was dropping like a rock before that for over a week. Even on green days where everything was up 5% it would drop 5%. I think CTS is ridiculous as well.